FierceBiotechOriginal article
{"a":[{"_":"Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs","$":{"href":"/biotech/deerfield-backed-boulevard-bio-strolls-65m-launch-and-trio-immunology-candidates","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Boulevard Bio launched from stealth with $65 million in Series A funding from Deerfield Management and three autoimmune disease candidates in development.
Importance:5/10
Sentiment:
0.60
immunologyautoimmune diseaseSeries A fundingstealth launch
Related Companies
Read the original article
Published by FierceBiotech on August 11, 2026 1:12 PM
